弘毅文化集团(00419)：出售Heartily Health Limited全部股权

智通财经

Jan 30

智通财经APP讯，弘毅文化集团(00419)发布公告，于2026年1月30日，卖方(Meerkat Health Holdings Limited，由公司全资拥有)与买方徐春生先生(Mr. XU Chun Sheng)订立买卖协议，据此，卖方已同意出售且买方已同意收购目标公司Heartily Health Limited的全部已发行股本;及卖方已同意向买方转让，而买方已同意受让股东贷款，总代价为1港元。

于完成后，公司将出售其于目标公司的全部股权，因此目标公司将不再为集团的附属公司。出售集团的财务业绩、资产及负债将不再并入集团综合财务报表。完成已于2026年1月30日落实。

目标公司为一间于中国香港注册成立的有限公司，主要从事投资控股。于出售前，目标公司由卖方全资拥有。目标公司连同其附属公司(即出售集团)主要从事医药电商互联网平台运营以及智慧医疗及医疗服务业务。出售集团的业务被归类为集团的经营分部之一，即“智慧医疗服务平台”。

出售事项使集团能够优化其资产配置，并专注于具有更强增长潜力的领域及业务。此举亦透过剔除亏损业务，使集团能够重新调配内部资源，以支持其现有主营业务娱乐及媒体;及医疗产业数字化运营服务的发展，从而增强集团整体的财务灵活性。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2607046549"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2607046549\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2607046549?lang=en_US&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2026-01-30 21:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2607046549","market":"fut","top_or_hot":-1,"title":"弘毅文化集团(00419)：出售Heartily Health Limited全部股权","media":"智通财经","content":"<html><body><p>智通财经APP讯，<a href=\"https://laohu8.com/S/00419\">弘毅文化集团</a>(00419)发布公告，于2026年1月30日，卖方(Meerkat Health Holdings Limited，由公司全资拥有)与买方徐春生先生(Mr. XU Chun Sheng)订立买卖协议，据此，卖方已同意出售且买方已同意收购目标公司Heartily Health Limited的全部已发行股本;及卖方已同意向买方转让，而买方已同意受让股东贷款，总代价为1港元。</p><p>于完成后，公司将出售其于目标公司的全部股权，因此目标公司将不再为集团的附属公司。出售集团的财务业绩、资产及负债将不再并入集团综合财务报表。完成已于2026年1月30日落实。</p><p>目标公司为一间于中国香港注册成立的有限公司，主要从事投资控股。于出售前，目标公司由卖方全资拥有。目标公司连同其附属公司(即出售集团)主要从事医药电商互联网平台运营以及智慧医疗及医疗服务业务。出售集团的业务被归类为集团的经营分部之一，即“智慧医疗服务平台”。</p><p>出售事项使集团能够优化其资产配置，并专注于具有更强增长潜力的领域及业务。此举亦透过剔除亏损业务，使集团能够重新调配内部资源，以支持其现有主营业务娱乐及媒体;及医疗产业数字化运营服务的发展，从而增强集团整体的财务灵活性。</p></body></html>","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>弘毅文化集团(00419)：出售Heartily Health Limited全部股权</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n弘毅文化集团(00419)：出售Heartily Health Limited全部股权\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-01-30 21:44 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1400093.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，弘毅文化集团(00419)发布公告，于2026年1月30日，卖方(Meerkat Health Holdings Limited，由公司全资拥有)与买方徐春生先生(Mr. XU Chun Sheng)订立买卖协议，据此，卖方已同意出售且买方已同意收购目标公司Heartily Health Limited的全部已发行股本;及卖方已同意向买方转让，而买方已同意受让股东贷款，总代价为1...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1400093.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02990","symbol_name":"弘毅文化集团","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1400093.html","article_id":"2607046549","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2607046549","pubTimestamp":1769780679,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，弘毅文化集团 发布公告，于2026年1月30日，卖方与买方徐春生先生订立买卖协议，据此，卖方已同意出售且买方已同意收购目标公司Heartily Health Limited的全部已发行股本;及卖方已同意向买方转让，而买方已同意受让股东贷款，总代价为1港元。于完成后，公司将出售其于目标公司的全部股权，因此目标公司将不再为集团的附属公司。于出售前，目标公司由卖方全资拥有。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"02990":"弘毅文化集团","00419":"弘毅文化集团","BK1241":"消闲设施","BK1148":"建筑与工程"},"translate_title":"Hony Culture Group (00419): Disposal of entire equity interest in Heartily Health Limited","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02990":1.5,"00419":1.5},"content_text":"智通财经APP讯，弘毅文化集团(00419)发布公告，于2026年1月30日，卖方(Meerkat Health Holdings Limited，由公司全资拥有)与买方徐春生先生(Mr. XU Chun Sheng)订立买卖协议，据此，卖方已同意出售且买方已同意收购目标公司Heartily Health Limited的全部已发行股本;及卖方已同意向买方转让，而买方已同意受让股东贷款，总代价为1港元。于完成后，公司将出售其于目标公司的全部股权，因此目标公司将不再为集团的附属公司。出售集团的财务业绩、资产及负债将不再并入集团综合财务报表。完成已于2026年1月30日落实。目标公司为一间于中国香港注册成立的有限公司，主要从事投资控股。于出售前，目标公司由卖方全资拥有。目标公司连同其附属公司(即出售集团)主要从事医药电商互联网平台运营以及智慧医疗及医疗服务业务。出售集团的业务被归类为集团的经营分部之一，即“智慧医疗服务平台”。出售事项使集团能够优化其资产配置，并专注于具有更强增长潜力的领域及业务。此举亦透过剔除亏损业务，使集团能够重新调配内部资源，以支持其现有主营业务娱乐及媒体;及医疗产业数字化运营服务的发展，从而增强集团整体的财务灵活性。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}